The Congressionally Directed Medical Research Programs (CDMRP) seeks feedback to inform the fiscal year 2027 (FY27) Alzheimer’s Research Program (AZRP) research focus areas and associated research funding opportunities. Although FY27 federal funds have not yet been appropriated, the AZRP is collecting this information solely to support strategic program planning. This inquiry does not commit the program to incorporating this feedback into FY27 or any future AZRP funding opportunities. The CDMRP wants to hear from all audiences, interested parties, and individuals from academia, industry, community and non-profit organizations, scientific and professional organizations, federal agencies, and the public. This RFI should not be construed as a solicitation or an obligation on the part of the AZRP or the Department of War (DoW).

BACKGROUND: The CDMRP represents a unique partnership between the U.S. Congress, the military, and the public to fund innovative and impactful medical research in targeted program areas. The CDMRP AZRP’s vision is to mitigate the impact of Alzheimer's and related dementias associated with TBI, military, and diverse risks. The AZRP’s mission is to fund impactful, solution-oriented research to address critical needs and improve quality of life for Service Members, Veterans, their Families, and the public who are living with Alzheimer's disease and related dementias. Appropriations for the AZRP from FY11-26 totaled $228 million. As of October 2026, FY27 funds for the AZRP have not been appropriated. If appropriated, the CDMRP will utilize its two-tier review process https://cdmrp.health.mil/about/2tierRevProcess) to efficiently manage the AZRP. Additional information about the AZRP can be found here: https://cdmrp.health.mil/azrp/ RESPONSE INSTRUCTIONS: Please provide responses to this RFI by clicking on the following link: https://www.surveymonkey.com/r/FY27-AZRP-RFI

RFI Alzheimer’s Research Program (AZRP) Public

Description

The rest of this notice